A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity

A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity

Abstract Background Typhoid fever is commonly found until today, especially in developing countries. It has fatal complications and measures must be taken to reduce the incidence of typhoid. Vaccinations are a key factor in prevention. This is a phase II randomized observer-blind clinical trial on a...

Full description

Bibliographic Details
Main Authors: Sukamto Koesnoe, Bernie Endyarni Medise, Iris Rengganis, Sri Rezeki Hadinegoro, Mita Puspita, Rini Mulia Sari, Jae Seung Yang, Sushant Sahastrabuddhe, Soedjatmiko, Hartono Gunardi, Rini Sekartini, Angga Wirahmadi, Aria Kekalih, Sreshta Mukhi, Hindra Irawan Satari, Novilia Sjafri Bachtiar
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Tropical Diseases, Travel Medicine and Vaccines
Subjects:
Typhoid Fever
Typhoid conjugate vaccine
Vi-DT
Vi-PS
Online Access:https://doi.org/10.1186/s40794-023-00210-z

Internet

https://doi.org/10.1186/s40794-023-00210-z

Similar Items